Advances in Understanding and Management of IgG4-Related Ophthalmic Disease.
Asia Pac J Ophthalmol (Phila)
; : 100101, 2024 Sep 24.
Article
in En
| MEDLINE
| ID: mdl-39326526
ABSTRACT
Immunoglobulin G4-related ophthalmic disease (IgG4-ROD) is an emerging, immune-mediated fibroinflammatory orbital disease, characterized by tumefactive lesions with noticeable IgG4+ plasma cell infiltration and distinctive pathohistological features. This disease is often associated with elevated serum IgG4 concentrations. IgG4-ROD may affect any ophthalmic tissues, particularly the lacrimal gland, extraocular muscles, and trigeminal nerves. Although the exact pathogenic role of IgG4 antibodies remains unclear, B-cell depleting agents have been reported to be an effective treatment. The diverse clinical manifestations of IgG4-ROD complicate diagnosis, and without prompt treatment, visual-threatening complications such as optic neuropathy may arise. Recent advances in understanding and managing IgG4-ROD have revolutionized the diagnosis and treatment of this emerging disease. This review article aims to provide a comprehensive overview of the latest advancements in the field of IgG4-ROD.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Asia Pac J Ophthalmol (Phila)
Year:
2024
Document type:
Article
Country of publication:
United States